Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
24.84
+0.64 (2.64%)
At close: Aug 13, 2025, 4:00 PM
24.78
-0.06 (-0.24%)
Pre-market: Aug 14, 2025, 9:25 AM EDT
Fresenius Medical Care AG Employees
Fresenius Medical Care AG had 111,513 employees as of December 31, 2024. The number of employees decreased by 8,332 or -6.95% compared to the previous year.
Employees
111,513
Change (1Y)
-8,332
Growth (1Y)
-6.95%
Revenue / Employee
$205,555
Profits / Employee
$6,913
Market Cap
14.62B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 111,513 | -8,332 | -6.95% |
Dec 31, 2023 | 119,845 | -8,199 | -6.40% |
Dec 31, 2022 | 128,044 | 5,135 | 4.18% |
Dec 31, 2021 | 122,909 | -2,455 | -1.96% |
Dec 31, 2020 | 125,364 | 4,705 | 3.90% |
Dec 31, 2019 | 120,659 | 8,001 | 7.10% |
Dec 31, 2018 | 112,658 | -1,342 | -1.18% |
Dec 31, 2017 | 114,000 | 4,681 | 4.28% |
Dec 31, 2016 | 109,319 | 5,286 | 5.08% |
Dec 31, 2015 | 104,033 | 4,138 | 4.14% |
Dec 31, 2014 | 99,895 | 9,205 | 10.15% |
Dec 31, 2013 | 90,690 | 4,537 | 5.27% |
Dec 31, 2012 | 86,153 | 6,994 | 8.84% |
Dec 31, 2011 | 79,159 | 5,707 | 7.77% |
Dec 31, 2010 | 73,452 | 5,464 | 8.04% |
Dec 31, 2009 | 67,988 | 3,322 | 5.14% |
Dec 31, 2008 | 64,666 | 3,260 | 5.31% |
Dec 31, 2007 | 61,406 | 4,603 | 8.10% |
Dec 31, 2006 | 56,803 | 9,282 | 19.53% |
Dec 31, 2005 | 47,521 | 2,995 | 6.73% |
Dec 31, 2004 | 44,526 | 3,429 | 8.34% |
Dec 31, 2003 | 41,097 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FMS News
- 3 days ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire
- 8 days ago - Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - PRNewsWire
- 23 days ago - Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy) - Seeking Alpha
- 27 days ago - $6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical - GlobeNewsWire
- 6 weeks ago - Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico - PRNewsWire
- 2 months ago - Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency - Benzinga
- 2 months ago - Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs - WSJ